Wellgistics Health Announces Pilot MSO Collaboration with Kare PharmTech Targeting $14 Billion U.S. Market for CCM and RPM ServicesMay 13, 2026
Russia develops dual-action cancer drug, a game-changer in oncology Featured News March 13, 2025 Russia pioneers theranostics with its first dual drug, improving prostate cancer diagnosis and therapy with innovative radiopharmaceuticals.
